Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood plasma boost for laser acne scar treatment?

NCT ID NCT07352215

Symptom relief Sponsor: Gujranwala medical college District Headquarters Hospital, Gujranwala Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether adding platelet-rich plasma (PRP) from your own blood to fractional CO2 laser therapy helps improve moderate-to-severe acne scars better than laser alone. Seventy adults aged 18-40 will receive three treatments, four weeks apart. The main goal is to see if scars look better, with less redness and swelling.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Platelet-rich plasma (PRP) applied topically after fractional CO2 laser treatment
What this could lead to
If it works, this could offer a better way to reduce acne scars with fewer side effects than laser alone.
What could go wrong
This is a small, early-stage trial with only 70 people. PRP may not add significant benefit, and results may not apply to all skin types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 70 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Apr 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 40 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria:Adults aged 18 to 40 years Male and female participants Fitzpatrick skin types I to V Presence of moderate-to-severe acne scars Willing to undergo 3 treatment sessions and follow-up visits Able to provide informed consent - Exclusion Criteria:Use of topical anti-acne medications in the past 1 month History of keloid formation or hypertrophic scarring Active acne or active skin inflammation at treatment area Diabetes mellitus Photosensitive disorders (e.g., lupus, dermatomyositis) Melasma Active infections (e.g., Herpes simplex) Recent laser resurfacing or similar procedures Outdoor workers with high sun exposure Vitiligo Pregnancy or breastfeeding Bleeding disorders or anticoagulant therapy Unrealistic expectations or inability to comply with follow-up \-

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Carbon dioxide lasers are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Carbon dioxide lasers Platelet rich plasma Post-acne atrophic scars

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Destrict Head Quarter Hospital, Gujranwala

    RECRUITING

    Gujranwala, Punjab Province, 52250, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.